Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.
Condition: Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer Intervention: Drug: Combination of Palbociclib and aromatase inhibitor (Letrozole or Anastrozole) Sponsors: International Cancer Research Group, United Arab Emirates; King Saud University Medical City, Riyadh, Saudi Arabia; Max-Planck-Institut für Quantenoptik (MPQ), and Faculty of Physics at Ludwig-Maximilians-Universität München (LMU), Garching, Germany; King Abdallah University for Scie nce and Technology (KAUST), Thuwal, Saudi Arabia. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Arimidex | Breast Cancer | Cancer | Cancer & Oncology | Germany Health | HER2 | Hormones | Middle East Health | Physics | Research | Saudi Arabia Health | UAE Health | Women